Clinical Trials Logo

Bulimia clinical trials

View clinical trials related to Bulimia.

Filter by:

NCT ID: NCT03604172 Completed - Clinical trials for Overweight and Obesity

Neural Response to Food Stimuli: fMRI Changes Following Cognitive Behavioral Therapy for Binge Eating Disorder

Start date: August 8, 2018
Phase: N/A
Study type: Interventional

The purpose of this research is to conduct a randomized controlled trial (RCT) assessing the impact of CBT on neural responses to binge eating stimuli.

NCT ID: NCT03540641 Completed - Clinical trials for Binge-Eating Disorder

Transcranial Magnetic Stimulation (TMS) in Binge Eating Disorder (BED)

TMS&BED
Start date: April 6, 2017
Phase: N/A
Study type: Interventional

This study evaluates de efficacy of 5Hz repetitive Transcranial Magnetic Stimulation (rTMS) applied on the left dorsolateral prefrontal cortex in patients with binge eating disorder.

NCT ID: NCT03539900 Completed - Clinical trials for Binge-Eating Disorder

Efficacy and Mechanisms of Naltrexone+Bupropion for Binge Eating Disorder

Start date: April 17, 2018
Phase: Phase 2/Phase 3
Study type: Interventional

This study will test the efficacy of naltrexone HCI and bupropion HCI (NB) versus placebo in patients with binge-eating disorder (BED), with or without obesity.

NCT ID: NCT03429114 Completed - Binge Eating Clinical Trials

Emotion Regulation in Binge Eating and Purging Among Adolescents

Start date: October 15, 2017
Phase:
Study type: Observational

The study will examine the neural and behavioral correlates of emotion regulation in adolescents engaging in binge eating and/or purging and healthy adolescents. Furthermore, it will look at the influence of executive function on emotion regulation in this population. This study will allow us to gain further understanding of the neural basis of emotion regulation in this age group. Moreover, this study supports the need to develop new treatment approaches based on a better understanding of the brain processes associated with eating disorders.

NCT ID: NCT03353649 Completed - Behavior Clinical Trials

Applying Novel Technologies and Methods to Inform the Ontology of Self-Regulation: Binge Eating and Smoking

Start date: December 8, 2017
Phase: N/A
Study type: Interventional

This study aims to examine targets of self-regulatory function among two exemplar populations for which behavior plays a critical role in health outcomes: smokers and individual who binge eat (BED). This is the second phase of a study that aims to identify putative mechanisms of behavior change to develop an overarching "ontology" of self-regulatory processes.

NCT ID: NCT03352713 Completed - Smoking Clinical Trials

Using Mobile Technology to Better Understand and Measure Self-Regulation

Start date: January 11, 2018
Phase: N/A
Study type: Interventional

This study will evaluate the extent to which we can engage and manipulate putative targets within the self-regulation domain outside of laboratory settings in samples of smokers and overweight/obese individuals with binge eating disorder. Fifty smokers and 50 overweight/obese individuals with binge eating disorder will be recruited to participate in a non-lab experimental paradigm in which we will leverage our novel mobile behavioral assessment/intervention technology platform. We will measure and modulate engagement of potential self-regulation targets and collect data in real time and in real-world conditions. Mobile sensing will be added to up to 50 additional participants.

NCT ID: NCT03348475 Completed - Clinical trials for Binge-Eating Disorder

Binge Focused Therapy: A Guided, Self-help, Group-based Approach for Binge Eating Disorder

Start date: February 1, 2018
Phase: N/A
Study type: Interventional

The "Brain Over Binge Recovery Guide" (Hansen, 2016), is a self-help approach that incorporates fundamental aspects of Acceptance and Commitment Therapy, Dialectical Behavioural Therapy, Motivational Enhancement Therapy and addictions treatment. This approach has been streamlined into a guided self-help protocol (Binge Focused Therapy, or BFT) that can be delivered by undergraduate students with minimal mental health experience in 3 group sessions spread over 8 weeks (i.e., Week 1, Week 2, Week 8). The aim of this proof-of-concept study is to provide preliminary data to examine whether this approach is feasible and has clinical potential for patients with binge eating disorder.

NCT ID: NCT03317379 Completed - Anorexia Nervosa Clinical Trials

Evaluation of the Communities of Healing Mentorship/Support Group Program: Assessment of Preliminary Efficacy

Start date: October 1, 2017
Phase: N/A
Study type: Interventional

The goal of the study is to evaluate two 6-month adjunct interventions (peer mentorship and social support mentorship) for individuals with eating disorders. Individuals will be randomized to peer-mentorship, social support mentorship, or a wait-list and eating disorder symptoms will be evaluated at baseline and post-treatment.

NCT ID: NCT03234881 Completed - Clinical trials for Binge Eating Disorder

Weight Loss Treatment for Veterans With Binge Eating

Start date: January 8, 2018
Phase: N/A
Study type: Interventional

Inclusion Criteria: aged 21 and older, BMI>=25, and presence of recurrent binge eating on the MOVE! Survey. Exclusion Criteria: more than 4 MOVE! sessions in the prior year; active psychosis or suicidal ideation; medical or psychiatric illness, or cognitive deficits that interfere with providing consent or completing assessments, and; pregnancy or lactation. Participants will be recruited from the VA's MOVE! Program at VA Connecticut Healthcare System (both Newington and West Haven campuses). Those participants who meet eligibility and are interested in the study will meet with a research associate who will obtain written consent. A baseline appointment will be made where the participant will complete written assessments, anthropometric measures (weight, height, blood pressure etc.), along with a blood draw. Participants will then be randomized, by luck of a draw, to either MOVE! or MOVE!+clinician-led CBT treatment. For those randomized to the MOVE! condition, participants will continue in the MOVE! program by meeting with the multidisciplinary team in a group setting once a week for 60 minutes, for 16 weeks. The group sessions are lead by a dietician, health psychologist, and physical therapist. For those randomized to the MOVE!+CBT treatments, participants will continue in the MOVE! program as described above, but will also partake in up to 10 individualized sessions over a 3-month period. Participants will be given a treatment manual to read at home, ask to complete daily food logs and work with the study therapist to create goals and complete homework that is geared at examining and changing how participant think about binge eating and how that thinking affects behavior. Lastly, a walking program will also be incorporated into the treatment. For both treatment arms, 3 months from treatment starting, then again at 9 months and 15 months, participants will be asked to complete post and follow up assessments, much like the baseline.

NCT ID: NCT03113669 Completed - Clinical trials for Binge-Eating Disorder

Project BITE: Binge Intervention Target Effectiveness

Start date: October 6, 2016
Phase: N/A
Study type: Interventional

The primary aim of this study is to determine how inhibitory neurobiological and neurocognitive processes relate to binge eating treatment outcome.